← Evidence map

ArticleJACC. Basic to translational science2019

Empagliflozin and HFrEF: Known and Possible Benefits of NHE1 Inhibition.

Seungho Jun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

6 papers cite it

2019
2020
2021
2022
2023
2024
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 31999274